By immunohistochemistry and RT-PCR on the micro-dissected samples, significant reduction of ERβ expression was indicated in grade 4/5 carcinomas while the majority of grade 3 carcinomas expressed ERβ in the peripheral zone of the prostate [115]. Here, ESR2 is linked to carcinoma.